Cardiac Glycoside
42 drugs across 14 manufacturers|39 Generic,3 Brand
The Cardiac Glycoside class contains 42 NDCs from 14 manufacturers (39 generic, 3 brand), at an average NADAC of $1.45 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
42
39G / 3B
Manufacturers
14
Avg $1.4511/unit
Avg 7d Change
+2.05%
Across 34 drugs with changes
7d Activity
of 42 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
14 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 2 more manufacturers
Frequently Asked Questions
How many drugs are in the Cardiac Glycoside class?
The Cardiac Glycoside class contains 42 NDCs from 14 manufacturers — 39 generic and 3 brand products.
What is the average price of Cardiac Glycoside drugs?
The average NADAC for the Cardiac Glycoside class is $1.4511 per unit across 42 NDCs.
Is generic cheaper than brand in the Cardiac Glycoside class?
Among products priced per EA, the average generic NADAC in this class is $0.6295, versus $11.6289 for brand — brand products average about 18× the generic price.
Which manufacturers make Cardiac Glycoside drugs?
14 manufacturers make drugs in the Cardiac Glycoside class. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (5), ANI Pharmaceuticals, Inc. (5), Hikma Pharmaceuticals USA Inc. (5), Amneal Pharmaceuticals of New York LLC (4), Sun Pharmaceutical Industries Inc. (4).
How has Cardiac Glycoside pricing changed recently?
Over the past 7 days, 34 NDCs in this class rose and 0 fell, with a class-wide average change of +2.0%.